Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MXCT

MaxCyte (MXCT)

MaxCyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MXCT
DateTimeSourceHeadlineSymbolCompany
12/27/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
12/26/20243:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MXCTMaxCyte Inc
12/23/20241:00AMGlobeNewswire Inc.MaxCyte Announces Retirement of Board Member Art MandellNASDAQ:MXCTMaxCyte Inc
12/10/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
12/09/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
12/09/20241:00AMGlobeNewswire Inc.MaxCyte Announces Streamlined Operations and Raises 2024 Revenue GuidanceNASDAQ:MXCTMaxCyte Inc
11/13/20246:14PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
11/13/20247:05AMGlobeNewswire Inc.MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based TherapeuticsNASDAQ:MXCTMaxCyte Inc
11/08/20244:31PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
11/06/20243:55PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MXCTMaxCyte Inc
11/06/20243:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
11/06/20243:05PMGlobeNewswire Inc.MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceNASDAQ:MXCTMaxCyte Inc
11/05/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
10/31/20243:23PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
10/31/20247:05AMGlobeNewswire Inc.MaxCyte to Participate in Two Upcoming Investor ConferencesNASDAQ:MXCTMaxCyte Inc
10/30/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
10/21/20243:11PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
10/16/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
10/16/20244:32PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
10/15/20243:40PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
10/15/20247:05AMGlobeNewswire Inc.MaxCyte Appoints Cynthia Collins to its Board of DirectorsNASDAQ:MXCTMaxCyte Inc
10/11/20247:05AMGlobeNewswire Inc.MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:MXCTMaxCyte Inc
10/10/20247:05AMGlobeNewswire Inc.MaxCyte Appoints Ali Soleymannezhad as Chief Commercial OfficerNASDAQ:MXCTMaxCyte Inc
10/02/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
09/30/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
09/26/20243:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MXCTMaxCyte Inc
09/18/20243:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
09/18/20243:28PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
09/16/20241:00AMGlobeNewswire Inc.MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic DiseasesNASDAQ:MXCTMaxCyte Inc
09/05/20243:05PMGlobeNewswire Inc.MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing ConferenceNASDAQ:MXCTMaxCyte Inc
 Showing the most relevant articles for your search:NASDAQ:MXCT